Report Categories
View AllRecent Articles
View All
SPKL Spark I management outlines nearterm SPAC merger search priorities ahead of key deal deadlines
Is Kyivstar KYIV stock relatively secure Q4 2025 EPS Beats Forecasts
Is 111 Inc YI stock failing to hold levels
What LEIFRAS LFS management said that matters most LFS Q3 Earnings Financial Metrics Remain Unavailable
Home Depot Comparable Sales Catch Up to Lowes Potentially Signaling Stock Performance Shift
Micron Technology Shares Eye Best Monthly Performance Since 1987 Analysts Flag Value Opportunity
Fed Rate Hike Expectations Jump as Inflation Surge Reshapes Market Outlook
WuXi Facility Secures Brazilian GMP Certification for Dengue Vaccine Production
Fitness Apps Disrupt Personal Training Flexibility and Risk in the Digital Workout Market
Suzlon Energy Surges as Deliveries Improve Q4 Revenue Jumps 45
AZTA Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Rally
CUZ Q1 2026 Earnings EPS Beat Highlights Operational Resilience
AVB Q1 2026 Earnings EPS Surpasses Estimates by 81 Amid Stable Multifamily Demand
LMFA Q1 2026 Earnings WiderThanExpected Loss Amidst Operational Challenges
BODI Q1 2026 Earnings Massive EPS Beat Masks Lingering Concerns as Stock Declines
BHP Q1 2026 Earnings EPS Miss Weighs on Sentiment as Commodity Headwinds Persist
Netclass Technology Inc NTCL Surges 45 Key Levels and Momentum in Focus
Nurix Therapeutics Shares Dip Slightly Holds Above Key Support NRIX
Akebia Therapeutics AKBA Edges Higher at 104 Key Levels in Focus
NVIDIA Sees Slight Decline Amid Key Support Test
Ping An Biomedical Holds Steady Near Key Support as Consolidation Continues
SENS Q1 2026 Earnings EPS Misses Estimates as Wider Loss Meets Surprise Stock Rises
ICCM Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development
BOBS Q1 2026 Earnings EPS Beats Estimates by Nearly 40 Despite Stock Decline
FRT Q1 2026 Earnings Stellar EPS Beat with 155 Surprise
IMCC Q1 2026 Earnings Disappointing EPS Amid Limited Disclosure Stock Surges
ORIC Q1 2026 Earnings Narrower Loss Misses Estimates as Clinical Development Continues